Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA’s Team Mentality: Commish Search Should Avoid Single-Candidate Focus

Executive Summary

The Obama Administration's search efforts for a new FDA commissioner should center on finding a team of qualified people - rather than just a single individual - to head the agency, panelists said at FDC-Windhover's FDA/CMS Summit Dec. 4

You may also be interested in...



Prasugrel Advisory Committee Highlights FDA’s Continued Credibility Gap

Controversy over a left-out member of the advisory committee for Lilly/Daiichi Sankyo's platelet inhibitor prasugrel illustrates the challenges that FDA continues to experience in ensuring the credibility of high-profile drug reviews

Prasugrel Advisory Committee Highlights FDA’s Continued Credibility Gap

Controversy over a left-out member of the advisory committee for Lilly/Daiichi Sankyo's platelet inhibitor prasugrel illustrates the challenges that FDA continues to experience in ensuring the credibility of high-profile drug reviews

Ex-FDA Commissioner Pleads Guilty To Conflicts Of Interest, False Statements

Former FDA Commissioner Lester Crawford pleaded guilty in D.C. federal court Oct. 17 to owning company stocks that caused conflicts of interest and to making false statements about those stock holdings during his tenure at the agency

Latest Headlines
See All
UsernamePublicRestriction

Register

PS050444

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel